Volume 14, Number 2—February 2008
Letter
Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
Asmaa Tazi*†‡, Thomas Gueudet§, Emanuelle Varon*, Liliane Gilly‡, Patrick Trieu-Cuot*¶, and Claire Poyart*†‡¶
Table
MICs of fluoroquinolones for strains of group B streptococci (GBS), France
| Strain |
MIC (mg/L)* | |||||
|---|---|---|---|---|---|---|
| Pef |
Nor |
Cip |
Spa |
Lev |
Mox |
|
| GBS CNR07017 | >64 | >64 | 4 | 1 | 4 | 1 |
| GBS NEM316 | 16 | 8 | 2 | 0.5 | 1 | 0.25 |
*Pef, pefloxacin; Nor, norfloxacin; Cip, ciprofloxacin; Spa, sparfloxacin; Lev, levofloxacin; Mox, moxifloxacin.
Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.